NCT03469167 (CEGP003) is a NA clinical trial of CEGP003 in Peptic Ulcer Bleeding, sponsored by CGBio Inc..

Who is sponsoring NCT03469167?

NCT03469167 is sponsored by CGBio Inc..

What drugs are being tested in NCT03469167?

Interventions in NCT03469167: CEGP003, Injection Tx.

What condition does NCT03469167 study?

NCT03469167 studies Peptic Ulcer Bleeding.

Is NCT03469167 still recruiting?

NCT03469167 is currently completed. Last updated 19 March 2018.

Last reviewed 2018-03-19 · How we verify

NCT03469167: CEGP003

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Study to Evaluate Efficacy and Safety of Wound Dressing Solution Containing EGF in Patients With Peptic Ulcers Bleeding

Completed NA Last updated 19 March 2018

What this trial tests

NA trial testing CEGP003 in Peptic Ulcer Bleeding in 76 participants. Completed in 2 January 2017.

Timeline

15 October 2014

Primary endpoint
10 November 2015

2 January 2017

Quick facts

Lead sponsor	CGBio Inc.
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	single
Primary purpose	treatment
Enrollment	76
Start date	15 October 2014
Primary completion	10 November 2015
Estimated completion	2 January 2017

Drugs / interventions tested

CEGP003
Injection Tx

Conditions studied

Peptic Ulcer Bleeding — all drugs for Peptic Ulcer Bleeding →

Sponsor

CGBio Inc.

Who can join

20 and older, any sex, with Peptic Ulcer Bleeding. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This is a prospective, single-blinded, randomized study to evaluate the efficacy and safety of CEGP003 in patients with acute peptic ulcers bleeding, compared to endoscopic epinephrine injection therapy.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Peptic Ulcer Bleeding

Currently open trials in the same condition.

NCT06894992 — Tegoprazan And Lansoprazole Effectiveness in Bleeding Peptic Ulcer Treatment · NA · recruiting

Other CGBio Inc. trials

Trials by the same sponsor.

NCT06715345 — Efficacy and Safety of Novosis Putty for Degenerative Lumbar Disease · NA · active not recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03469167 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by CGBio Inc.
Last refreshed: 19 March 2018

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03469167.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing